0
0
Loading version...
🔄 Update App
🔍 Check for Updates
Test Notification
🔔 Enable Notifications
📰 Fetch NHK News
🚀 Fetch TechCrunch News
🧪 Experiment
📰 Article Management
📚 Reading List
🎤 Speaking List
📊 Statistics
💻 Software Statistics
Push Admin
Edit Reading
Back to List
Basic Information
Title
Please enter a title.
URL
Please enter a valid URL.
Date
カテゴリID
画像ファイル名
統計情報
単語数:
144語
読了回数:
0回
作成日:
2024/09/21 07:00
更新日:
2025/12/08 10:25
本文
本文
Japan's health ministry has approved five types of coronavirus vaccines for use in this season's campaign that starts on October 1. People aged 65 or older and those between 60 and 64 years old with a high risk of developing severe COVID symptoms are eligible for the campaign. The five types approved on Thursday include a new product called a replicon RNA vaccine that is capable of self-amplifying mRNA, or messenger RNA, which helps produce antibodies to the virus. The others are three mRNA vaccines that have already been used in Japan and a recombinant protein vaccine. The fee differs by municipalities. The central government will provide local governments with a per-shot subsidy of 8,300 yen, or about 58 dollars, to cap a copayment of under about 50 dollars. People who are not eligible for the campaign will have to pay the full expense.
本文を入力してください。
メモ
メモ・感想
キャンセル
更新
Debug Info:
Saved State:
-
Redirected Flag:
-
Current URL:
-
Refresh
Close
Debug
Send Report
Send Report
Draw Arrow
Clear
Message:
Cancel
Send
